Emma Bolderson

3.5k citations
62 papers · 2.5k · 1 hit paper · h-index 25

Impact in

  • Oncology top 5%
    • PARP inhibition in cancer therapy
    • Cancer-related Molecular Pathways
    • DNA Repair Mechanisms
    • CRISPR and Genetic Engineering
    • RNA Research and Splicing
    • Genomics and Chromatin Dynamics
    • DNA and Nucleic Acid Chemistry
    • RNA modifications and cancer

Papers in

    • DNA Repair Mechanisms 39
    • Genomics and Chromatin Dynamics 12
    • Nuclear Structure and Function 12
    • DNA and Nucleic Acid Chemistry 8
    • CRISPR and Genetic Engineering 6
    • PARP inhibition in cancer therapy 9
    • Cancer-related Molecular Pathways 7

Emma Bolderson

60 papers receiving 2.5k citations

Emma Bolderson's Hit Papers

PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance 2020 · 477 citations
4770+2+4Years since publication100200300400

Peers

Emma Bolderson
Comparison fields: 5 of 97
  • Oncology 776
  • Molecular Biology 1.8k
  • Cancer Research 346
  • Genetics 214
  • Cell Biology 122
Replace Ricardo Sánchez‐Prieto with:
Ricardo Sánchez‐Prieto Spain
Qi‐En Wang United States
Julio C. Morales United States
Junhong Han China
Nicholas D. Lakin United Kingdom
Susan Wee United States
Xavier Jacq United Kingdom
Kuntian Luo China
Vanesa Gottifredi Argentina
Andrew C. Phillips United States
Emma Bolderson relative to Ricardo Sánchez‐Prieto Spain Ricardo Sánchez‐Prieto's profile →
Citations per field
00.5×3.5×
Ricardo Sánchez‐Prieto · 1×
Citations per year

Countries citing papers authored by Emma Bolderson

Since Specialization
Citations

This map shows the geographic impact of Emma Bolderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Bolderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Bolderson more than expected).

Fields of papers citing papers by Emma Bolderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma Bolderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Bolderson. The network helps show where Emma Bolderson may publish in the future.

Co-authors

The 25 scholars most cited alongside Emma Bolderson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Emma Bolderson Line = papers co-authored together Emma Bolderson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#Work
1
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Hit paper breakdown →
2020477
2 2008194
3 2016194
4 2009142
5 201493
6 200991
7 200985
8 201384
9 201477
10 200476
11 200975
12 201066
13 201166
14 201555
15 202153
16 201945
17 201245
18 202144
19 202241
20 202041

About Emma Bolderson

Emma Bolderson is a scholar working on Molecular Biology, Oncology, Cancer Research, Cell Biology and Immunology, having authored 62 papers that have together received 2.5k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (39 papers), Genomics and Chromatin Dynamics (12 papers), Nuclear Structure and Function (12 papers), PARP inhibition in cancer therapy (9 papers), Carcinogens and Genotoxicity Assessment (8 papers), DNA and Nucleic Acid Chemistry (8 papers), Cancer-related Molecular Pathways (7 papers) and CRISPR and Genetic Engineering (6 papers). The work is most often cited by research in Oncology (776 citations), Molecular Biology (1.8k citations), Cancer Research (346 citations), Genetics (214 citations) and Cell Biology (122 citations). Emma Bolderson has collaborated with scholars based in Australia, United Kingdom and United States. Frequent co-authors include Derek J. Richard, Kenneth J. O’Byrne, Joshua T. Burgess, Kum Kum Khanna, Maddison Rose, Mark N. Adams, Didier Boucher, Liza Cubeddu, Nicolas Paquet and Amila Suraweera. Their work appears in journals such as Nucleic Acids Research, Frontiers in Cell and Developmental Biology, Scientific Reports, BMC Molecular Biology and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact